Author

E. Nuermburger

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:mouse· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Approach:experimental assay· 1 Approach:statistical model· 1

Frequent Co-Authors

R. Tasneen· 2 shared A. A. Bauman· 1 shared C. Dide-Agossou· 1 shared C. M. Moore· 1 shared G. T. Robertson· 1 shared J. H. Grosset· 1 shared K. Rossmassler· 1 shared M. E. Ramey· 1 shared

Activity by Year

2019-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

R. Tasneen

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Combination of Mycobacterium tuberculosis RS ratio and CFU improves the ability of murine efficacy experiments to distinguish between drug treatments

C. Dide-Agossou, A. A. Bauman, M. E. Ramey, K. Rossmassler, R. Al Mubarak, S. Pauly, M. I. Voskuil, M. Garcia?Cremades, R. M. Savic, P. Nahid, C. M. Moore, R. Tasneen, E. Nuermburger, G. T. Robertson, N. D. Walter

bioRxiv · Dec 21, 2021Microbiology

Treatment-shortening effect of a novel regimen combining high-dose rifapentine and clofazimine in pathologically distinct mouse models of tuberculosis

V. Saini, N. C. Ammerman, Y. S. Chang, R. Tasneen, R. Chaisson, S. K. Jain, E. Nuermburger, J. H. Grosset

This study tests a new TB treatment regimen combining high-dose rifapentine and clofazimine in mouse models, finding it more effective than either drug alone in shortening treatment duration.

bioRxiv · Feb 21, 2019Microbiology